G

ood morning, everyone, and welcome to the middle of the week. This is, of course, a typically busy time, but today is busier than usual as we play catch up, having returned from a quick distraction yesterday. To compensate, we are scurrying about to gather some interesting items we may have missed while away. To maintain this hurried pace, yes, we are quaffing a few cups of stimulation and, as always, invite you to join us. So please hoist your own cup as you dig in to the tidbits below. Have a swell day and do stay in touch …

The Greek parliament will decide today whether to conduct a preliminary inquiry into whether there is sufficient evidence to prosecute two former prime ministers and eight former ministers in the Novartis (NVS) bribery case, the Associated Press writes.  The case is based on depositions of three protected witnesses, among others, who allege the drug maker offered bribes in order to boost sales of its medicines. The drug maker has denied the accusations and says it is cooperating with Greek authorities.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy